Reliance Global Group, Inc. (EZRA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 27.22%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 27.22% | Share-based compensation / revenue. Period ending 2026-06-30. $3.01M ÷ $11.05M × 100 ≈ 27.22% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 11.05M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 3.01M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -8.30M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $11.05M | $3.01M | $-8.30M | (m) | (m) | 27.22% | (m) | (m) |
| 2026-03-31 | (m) | $12.02M | $3.87M | $-8.85M | (m) | (m) | 32.18% | (m) | (m) |
| 2025-12-31 | (m) | $12.43M | $4.83M | $-9.01M | $1.04M | (m) | 38.83% | -8.64× | Reported |
| 2025-09-30 | (m) | $13.12M | $4.85M | $-8.70M | (m) | (m) | 36.98% | (m) | (m) |
| 2025-06-30 | (m) | $14.06M | $2.12M | $-5.30M | (m) | (m) | 15.09% | (m) | (m) |
| 2025-03-31 | (m) | $14.21M | $1.49M | $-4.07M | (m) | (m) | 10.49% | (m) | (m) |
| 2024-12-31 | (m) | $14.05M | $533.63K | $-7.70M | (m) | (m) | 3.80% | (m) | (m) |
| 2024-09-30 | (m) | $14.08M | $1.05M | $-16.29M | (m) | (m) | 7.42% | (m) | (m) |
| 2024-06-30 | (m) | $13.91M | $1.06M | $-17.21M | (m) | (m) | 7.62% | (m) | (m) |
| 2024-03-31 | (m) | $13.88M | $849.88K | $-17.91M | (m) | (m) | 6.13% | (m) | (m) |
| 2023-12-31 | (m) | $13.73M | $875.11K | $-13.88M | (m) | (m) | 6.37% | (m) | (m) |
| 2023-09-30 | (m) | $18.44M | $123.52K | $-20.53M | (m) | (m) | 0.67% | (m) | (m) |
| 2023-06-30 | (m) | $17.99M | $409.99K | $-20.42M | (m) | (m) | 2.28% | (m) | (m) |
| 2023-03-31 | (m) | $16.46M | $553.71K | (m) | (m) | (m) | 3.36% | (m) | (m) |
| 2022-12-31 | (m) | $16.76M | $1.25M | $-21.70M | (m) | (m) | 7.46% | (m) | (m) |
| 2022-09-30 | (m) | $15.21M | $1.32M | $-6.71M | (m) | (m) | 8.65% | (m) | (m) |
| 2022-06-30 | (m) | $13.64M | $1.15M | $-5.67M | (m) | (m) | 8.41% | (m) | (m) |
| 2022-03-31 | (m) | $11.62M | $1.14M | $-4.83M | (m) | (m) | 9.78% | (m) | (m) |
| 2021-12-31 | (m) | $9.71M | $749.13K | $-2.91M | (m) | (m) | 7.71% | (m) | (m) |
| 2021-09-30 | (m) | $9.07M | $1.07M | $-2.78M | (m) | (m) | 11.85% | (m) | (m) |
| 2021-06-30 | (m) | $8.17M | $1.15M | $-3.40M | (m) | (m) | 14.07% | (m) | (m) |
| 2021-03-31 | (m) | $7.57M | $1.43M | $-3.35M | (m) | (m) | 18.87% | (m) | (m) |
| 2020-12-31 | (m) | $7.28M | $1.47M | $-3.64M | (m) | (m) | 20.21% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $4.45M | $1.05M | $-3.10M | (m) | (m) | 23.53% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| eHealth, Inc. (EHTH) | United States | $0.026B | 1.75 |
| SelectQuote, Inc. (SLQT) | United States | $0.073B | 2.34 |
| Roadzen Inc. (RDZN) | United States | $0.109B | |
| Goosehead Insurance, Inc. (GSHD) | United States | $0.922B | 276.12 |
| Baldwin Insurance Group, Inc. (BWIN) | United States | $1.083B | -498.48 |
| CORVEL CORP (CRVL) | United States | $3.727B | 27.41 |
| RYAN SPECIALTY HOLDINGS, INC. (RYAN) | United States | $4.038B | 67.32 |
| Equitable Holdings, Inc. (EQH) | United States | $14.367B | -12.94 |
| BROWN & BROWN, INC. (BRO) | United States | $20.190B | 17.57 |
| WILLIS TOWERS WATSON PLC (WTW) | $27.268B | 15.77 |